International Journal of Mental Health & Psychiatry.ISSN: 2471-4372

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Editorial,  Int J Ment Health Psychiatry Vol: 5 Issue: 3

Market Analysis on World Congress on Psychiatry and Mental Health

Sam Vaknin

Professor of Psychology, Southern Federal University, Rostov-on-Don, Russia, E-mail: [email protected]

Keywords: Psychiatry

On behalf of Lexis Conferences Organizing Committee we cordially welcomes all the participants and contributors from worldwide to attend World Congress on Psychiatry and Mental Health which is going to be held in San Francisco, USA during November 05-06,2020 across the theme “Exploring Innovative Therapies to Achieve Mental and Physical Wellness”.

We invite you to join us at Psychiatry, Mental Disorders and Psychosomatic Medicine Conference where you will be sure to have a meaningful experience with scholars from around the world. Generous response and active participation from the Editorial Board Members of conference related Journals as well as from the scientists, researchers and leaders in the field of will make this conference as one of the most successful and productive events in 2020.

Psychiatry is the branch of medicine focused on the diagnosis, treatment and prevention of mental, emotional and behavioral disorders. A psychiatrist is a medicinal specialist who represents considerable authority in psychological well-being, including substance utilizes clutters. Therapists are met all requirements to survey both the mental and physical parts of mental issues. Our main goal is to make Annual Congress on Mental Health an extraordinary accomplishment with world class talks and discussion by the best Psychiatrists and Psychologists in the field.

The Psychiatric Hospitals industry is made up of hospitals that specialize in the treatment of mental illness and behavioural health. The industry is mainly supported by government-sponsored healthcare, which accounts for nearly two-thirds of mental healthcare spending in the United States, according to the US Department of Health and Human Services. As a result, the expansion of Medicare and Medicaid has had a significant effect on the Psychiatric Hospitals industry. Over the five years to 2019, federal funding for Medicare and Medicaid has increased at an annualized rate of 4.0% as a result of healthcare reform. In addition, wider acceptance and prevalence of mental illness has also supported demand for behavioural health treatment.

Psychiatrists Global Market Trend:

Digital psychotherapy is a major trend in psychiatrists market. The digital age has entered in the area of psychotherapy; this is called digital psychotherapy. Digital psychotherapy enables people with disabilities and people in remote areas to have access to therapy and education of their problems. Some counsellors are already using this technology to hold therapy sessions.

The companies covered are Massachusetts General Hospital, Boston, McLean Hospital, Presbyterian University Hospital of Columbia and Cornell, Johns Hopkins Hospital, and Menninger Clinic.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

This report on Psychiatric Hospitals Industry in the US:

Provides Market Size information to assist with planning and strategic decisions.

Includes the necessary information to perform SWOT, PEST and STEER analysis.

Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.

Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.

Psychiatrists Global Market Size:

The global psychiatrists market was valued at $795.1 billion in 2017. North America was the largest geographic region accounting for $380.1 billion or 47.8% of the global market. The USA was the largest country accounting for $318.8 billion or 40% of the global psychiatrists market.

Market Analysis for Pediatric Medicines

The global market for pediatric medicines reached $80.7 billion in 2013 and should reach $83.6 billion in 2014. This market is expected to reach about $100.7 billion by 2019, registering a compound annual growth rate (CAGR) of 3.8% from 2014 to 2019.

Market Analysis of Anti-Psychotic Drugs

The global market for antipsychotic drugs should grow from $13.2 billion in 2018 to reach $14.5 billion by 2023 at a compound annual growth rate (CAGR) of 1.9% for the period of 2018-2023.

Market Analysis for CNS Biomarker Market

The global CNS biomarker market is projected to reach $5.1 billion by 2020 from $3.1 billion in 2015, at a compound annual growth rate (CAGR) of 10.4%.

Fund Allotment to Psychiatry Research

NIHR- National Institute for Health Research- $1.05 bi

HBP- Human Brain Project - $ 1.3bi

BRI- Brain Research Initiative -$ 0.1 bi

Mental illness’ and ‘Mental disorder’ are the terms used to describe a spectrum of mental health and behavioral disorders in Australia. National Survey of Mental Health and Wellbeing was started in 1990 in Australia. The role of this survey is to measure the number of population and the amount of disability with mental health disorders and mental health services used by the people. The importance of fine mental state and its impact on Australians have long been recognized by the Australian government and every one state and territory governments. Over the last three decades, these governments have worked along, via the National Mental State Strategy, to develop mental state programs and services to raised address the mental state needs of Australians.

In 2015-16, Australian Institute of Health and Welfare was estimated that around $9.0 billion or $373 per person was spent on mental health-related services. Out of 9.0 billion USD $5.4 billion (59.8%) was funded by state and territory governments, $3.1 billion (35%) were funded by the Australian government and $466 million (5.2%) was funded by private health insurance funds.

National Institute for Health Research

In 2012/13, NIHR had a total research cost of £958.9m, research program’s- £208.9 m and on infrastructure-£618.9 m. The Faculty members of NIHR including senior investigators and fellowships received £100 m.

image

Track Your Manuscript

Recommended Conferences

9th Annual Congress on Neuroscience & Therapeutics

Osaka, Japan

Share This Page